Evidence map›Paper›PMID 28030575›Full record

ArticlePloS one2016

Time Course of Leptin in Patients with Anorexia Nervosa during Inpatient Treatment: Longitudinal Relationships to BMI and Psychological Factors.

Esther Stroe-Kunold, Magdalena Buckert, Hans-Christoph Friederich, Daniela Wesche, Stefan Kopf, Wolfgang Herzog, Beate Wild

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 3 pooled it
0.8field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 3 syntheses or guidelines pooled it, 27 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Article
  6. Article
  7. Article
  8. Observational
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Neuropsychological and Cognitive Correlates of Recovery in Anorexia Nervosa.European eating disorders review : the journal of the Eating Disorders Association · 2017
    Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Esther Stroe-KunoldDepartment of General Internal Medicine and Psychosomatics, Medical University Hospital, Heidelberg, Germany.
Magdalena BuckertDepartment of General Internal Medicine and Psychosomatics, Medical University Hospital, Heidelberg, Germany.
Hans-Christoph FriederichDepartment of Psychosomatic Medicine and Psychotherapy, LVR-Clinics, University Düsseldorf, Düsseldorf, Germany.
Daniela WescheDepartment of General Internal Medicine and Psychosomatics, Medical University Hospital, Heidelberg, Germany.
Stefan KopfDepartment of Endocrinology and Clinical Chemistry, Medical University Hospital, Heidelberg, Germany.
Wolfgang HerzogDepartment of General Internal Medicine and Psychosomatics, Medical University Hospital, Heidelberg, Germany.
Beate WildDepartment of General Internal Medicine and Psychosomatics, Medical University Hospital, Heidelberg, Germany.
Heidelberg University · DEHeinrich Heine University Düsseldorf · DEUniversity Hospital Heidelberg · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundLeptin, a hormone secreted by adipose tissue, appears to play a major role in the homeostasis of body weight and psychobiological processes associated with anorexia nervosa (AN). However, there is scarce data on its exact influence on this disorder, in particular data over time.

objectiveThe present study addresses whether leptin changes during inpatient treatment play a role for treatment outcome and psychological factors in underweight AN patients.

methodsIn order to understand whether leptin's role differs in relation to AN severity, data were assessed from 11 patients with a very low BMI and a higher chronicity (high severity group; HSS; mean BMI at the beginning of the study = 13.6; mean duration of illness = 5.1 years) vs. nine with less severe symptoms (LSS; mean BMI = 16.2; mean duration of illness = 3.7 years). During the course of treatment, serum leptin concentrations were assessed weekly while weight (BMI) was assessed twice per week. Concomitantly, psychological variables were obtained by means of electronic diaries. Unconditional linear growth models were calculated to evaluate the temporal course of leptin in relation to BMI. For HSS patients, two phases of treatment (BMI < 16 and BMI ≥ 16 kg/m2) were investigated.

resultsLeptin increased significantly with BMI in both groups of patients. For HSS patients, the increase of leptin in the first treatment phase did not predict later increases in BMI. Furthermore, the relationship of leptin and psychological factors was modulated by symptom severity. In HSS patients, higher leptin levels were associated with greater feelings of depression, anxiety, and stress whereas in LSS patients a higher leptin level showed the trend to be associated with lower psychological symptom burden.

conclusionsOur results suggest that leptin changes are differently associated with weight gain and psychological symptoms depending on the severity of starvation.

Indexed as

Body Mass IndexAdolescentAdultAnorexia NervosaBody WeightCase-Control StudiesDepressionFemaleHumansInpatientsLeptinLongitudinal StudiesMaleMiddle AgedPatient DischargeYoung AdultLeptin

Identifiers

PMID28030575
PMCPMC5193359
OpenAlexW2562622139

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.